• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

5 of Today's Biggest Marijuana Stock Gainers - Tuesday, April 3rd

April 3, 2018

 

Out of over 200+ marijuana stockshere are 5 of the biggest marijuana stock winners in trading on Tuesday, April 3rd including GW Pharmaceuticals Plc. (NASDAQ:GWPH) and more...

 

Axim Biotechnologies, Inc. (OTC:AXIM)

 

Shares of Axim Biotechnologies, Inc. rose 9.59% on lower than average trading volume on the OTC markets, closing the day at $4.00 USD per share. Recently, AXIM entered into a binding distribution agreement for its proprietary cannabinoid-based nutraceutical chewing gum product, CanChew+.

 

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

 

Shares of GW Pharmaceuticals Plc. rose 5.39% on higher than average trading volume on the NASDAQ, closing the day at $111.57 USD per share. Recently, GW Pharma received Notices of Allowance from the U.S. Patent and Trademark Office for five new Epidiolex patent applications.

 

Insys Therapeutics Inc. (NASDAQ:INSY)

 

Shares of Insys Therapeutics Inc. rose 7.38% on lower than average trading volume on the NASDAQ, closing the day at $6.40 USD per share. Yesterday, Insys announced the appointment of Trudy Vanhove as a new independent member of its Board of Directors. Given her extensive experience in clinical development and medical affairs, Dr. Vanhove will also serve on the Board’s R&D committee.

 

Marrone Bio Innovations, Inc. (OTC:MBII)

 

Shares of Marrone Bio Innovations, Inc. rose 14.22% on higher than average trading volume on the NASDAQ, closing the day at $2.49 USD per share. Yesterday, Marrone Bio Innovations announced that management is scheduled to present at The MicroCap Conference in New York City. The conference is being held on April 9-10, 2018 at the JW Marriott Essex House.

 

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE)

 

Shares of Zynerba Pharmaceuticals, Inc. rose 14.16% on higher than average trading volume on the NASDAQ, closing the day at $9.11 USD per share. Recently, Zynerba announced that researchers at The Scripps Research Institute and the University of Maryland have generated preclinical data from a study funded by NIH grants that suggest potential value in using Zynerba's transdermal CBD to reduce the risk of relapse among recovering drug and alcohol addicts.

 

Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!

 

Conclusion

 

Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!

 

D/M/O

 

 

Disclaimer

 

Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.

Read more articles tagged:

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.